4 research outputs found
Study of senescence and possible mechanisms involved in arsenic-induced carcinogenesis in humans
Arsenic (As) induces various patho-physiological outcomes in humans like cancers including skin cancers, peripheral neuropathy (PN) and respiratory diseases. Though reports
have shown that arsenic induced senescence (AIS) in vitro; population based studies on AIS and epigenetic regulation of AIS contributing to As-induced diseases remains unexplored. We investigated AIS, senescence-associated secretory phenotype (SASP) markers, telomere
length alteration, epigenetic regulation involving altered senescence associated miRNA (SAmiRs)
expression in arsenic exposed individuals with characteristic skin lesions and
peripheral neuropathy. We also made an attempt to check the genetic damage, overall health
status and telomere length in arsenic exposed children. Exposure assessment was done from
drinking water and urine collected from arsenic exposed (N=120) and unexposed (N=60)
individuals recruited from West Bengal, India. Senescence and telomere length alteration was
evaluated using SA Ξ²-gal activity, ELISA and quantification of senescence proteins,
alternative lengthening of telomere (ALT) associated proteins and telomerase activity.
Relative telomere length (RTL) and SA-miRs in AIS was determined by qPCR. The
downstream molecule of the miRNA associated with As-induced PN was quantified by
immuoblotting. In vitro studies were conducted with sodium arsenite exposed HEK 293 cells,
to revalidate the observations.
As-exposed individuals exhibited significantly increased senescent cells, upregulated
senescence inducers, p53/p21 and SASP markers when compared to unexposed controls. Asexposed
skin lesion group showed significantly increased RTL, which was telomeraseindependent
but exhibited an over-expression of ALT associated proteins. All the SA-miRs
assessed were upregulated in the As-exposed compared to controls, specifically miR-29a.
Further analysis found that highest expression of miR29a and peripheral myelin protein 22
(PMP22), a direct target of miR 29a, was among As-exposed individuals with PN. Analyzing
other intermediate players regulating PMP22 expression revealed up-regulation of Ξ²-catenin
and down-regulation of GSK-3Ξ². Our findings suggest that up-regulation of Ξ²-catenin,
possibly by miR29a mediated negative regulation of Ξ²-catenin inhibitors, may play a
predominant role in expression of PMP22 which leads to formation of aggresomes. Further
work to validate this mechanism is in process in vitro. Arsenic exposed children showed
considerable genetic damage as measured by micronucleus assay in the three cell types and
also adverse health outcomes like decreased haemoglobin content and gastritis. Telomere
length of arsenic exposed children was slightly elevated though it did not reach the
significance level.
Our findings suggest that arsenic exposure induces senescence in vivo and telomeraseindependent
elongation of telomere length is strictly associated with As-induced skin lesions
in adults. Epigenetically, arsenic alters the expression of SA-miRs and the mir29a/beta
catenin/PMP22 axis might be responsible for arsenic induced PN. However, in children, the
telomere length increase and genetic damage in the three cell types and adverse health
outcomes suggested that children are equally at danger of arsenic poisoning
Arsenic Exposure through Drinking Water Leads to Senescence and Alteration of Telomere Length in Humans: A Case-Control Study in West Bengal, India
Arsenic (As) induces pre-malignant and malignant dermatological lesions, non-dermatological health effects and cancers
in humans. Senescence involves telomere length changes and acquisition of senescence-associated secretory phenotype
(SASP), which promotes carcinogenesis. Though in vitro studies have shown that As induces senescence, population based
studies are lacking. We investigated the arsenic-induced senescence, telomere length alteration and its contribution
towards development of As-induced skin cancer. The study participants included 60 each of As-exposed individuals with
skin lesion (WSL), without skin lesions (WOSL) and 60 unexposed controls. Exposure assessment of drinking water and urine
was done. SA b-gal activity, ELISA, and quantification of senescence proteins, alternative lengthening of telomere (ALT)
associated proteins and telomerase activity were performed. Relative telomere length (RTL) was determined by qPCR. A
significantly higher number of senescent cells, over-expression of p53 and p21 were observed in the As-exposed individuals
when compared to unexposed. SASP markers, MMP-1/MMP-3 were significantly higher in the WSL but not IL-6/IL-8. A
significant increase of RTL was observed in the WSL group, which was telomerase-independent but exhibited an overexpression
of ALT associated proteins TRF-1 and TRF-2 with higher increase in TRF-2. An increased risk for developing Asinduced
skin lesions was found for individuals having RTL greater than 0.827 (odds ratio, 13.75; 95% CI: 5.66β33.41;
P<0.0001). Arsenic induces senescence in vivo, but the SASP markers are not strictly over-expressed in the As-induced skin
lesion group, whereas telomerase-independent elongation of telomere length might be useful for predicting the risk of
development of As-induced skin lesion
Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India
Abstract Background Arsenic is a natural drinking water contaminant affecting 26 million people in West Bengal, India. Chronic arsenic exposure causes cancer, cardiovascular disease, liver disease, neuropathies and ocular diseases. The aims of the present study were to assess bioindicators of hepatocellular injury as indicated by the levels of liver enzymes, to determine the auto immune status, as indicated by the amounts of anti-nuclear antibodies (ANA) and anti-dsDNA antibodies in their serum, and to predict cardiovascular risk in the arsenic exposed population. Methods Effect of chronic arsenic exposure on liver was determined by liver function tests. Autoimmune status was measured by measuring ANA and anti-dsDNA in serum. Inflammatory cytokines associated with increased cardiovascular disease risk, IL6, IL8 and MCP-1 were determined. Results Our results indicated that serum levels of bilirubin, alanine transaminase, aspartate transaminase, alkaline phosphatase and ANA were increased in the arsenic exposed population. Serum levels of IL6 and IL8 also increased in the arsenic exposed group. Conclusions Chronic arsenic exposure causes liver injury, increases the serum levels of autoimmune markers and imparts increased cardiovascular risk.</p
Arsenic Exposure Through Drinking Water Increases the rRsk of Liver and Cardiovascular Diseases in the Population of West Bengal, India
Background: Arsenic is a natural drinking water contaminant affecting 26 million people in West Bengal, India.
Chronic arsenic exposure causes cancer, cardiovascular disease, liver disease, neuropathies and ocular diseases. The
aims of the present study were to assess bioindicators of hepatocellular injury as indicated by the levels of liver
enzymes, to determine the auto immune status, as indicated by the amounts of anti-nuclear antibodies (ANA) and
anti-dsDNA antibodies in their serum, and to predict cardiovascular risk in the arsenic exposed population.
Methods: Effect of chronic arsenic exposure on liver was determined by liver function tests. Autoimmune status
was measured by measuring ANA and anti-dsDNA in serum. Inflammatory cytokines associated with increased
cardiovascular disease risk, IL6, IL8 and MCP-1 were determined.
Results: Our results indicated that serum levels of bilirubin, alanine transaminase, aspartate transaminase, alkaline
phosphatase and ANA were increased in the arsenic exposed population. Serum levels of IL6 and IL8 also increased
in the arsenic exposed group.
Conclusions: Chronic arsenic exposure causes liver injury, increases the serum levels of autoimmune markers and
imparts increased cardiovascular risk.
Keywords: Arsenic, Antinuclear antibody, Liver function tests, Cytokine